Jane Street
TVTX icon

Jane Street’s Travere Therapeutics TVTX Stock Holding History

Jane Street’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.69M Sell
191,600
-65,200
-25% -$1.95M ﹤0.01% 3318
2025
Q4 		$9.81M Sell
256,800
-65,400
-20% -$2.13M ﹤0.01% 2342
2025
Q3 		$7.7M Sell
322,200
-164,000
-34% -$3.08M ﹤0.01% 2772
2025
Q2 		$7.2M Buy
486,200
+281,200
+137% +$4.66M ﹤0.01% 2543
2025
Q1 		$3.67M Sell
205,000
-57,300
-22% -$1.16M ﹤0.01% 3391
2024
Q4 		$4.57M Buy
262,300
+166,400
+174% +$2.94M ﹤0.01% 2791
2024
Q3 		$1.34M Buy
95,900
+85,600
+831% +$892K ﹤0.01% 5283
2024
Q2 		$84.7K Sell
10,300
-200
-2% -$1.35K ﹤0.01% 8791
2024
Q1 		$81K Sell
10,500
-32,800
-76% -$277K ﹤0.01% 8605
2023
Q4 		$389K Sell
43,300
-13,900
-24% -$101K ﹤0.01% 7205
2023
Q3 		$511K Buy
57,200
+31,800
+125% +$449K ﹤0.01% 6265
2023
Q2 		$390K Buy
+25,400
New +$462K ﹤0.01% 6693
2022
Q3 		– Sell
-15,600
Closed -$378K – 10491
2022
Q2 		$378K Sell
15,600
-26,200
-63% -$659K ﹤0.01% 7218
2022
Q1 		$1.08M Buy
41,800
+19,700
+89% +$523K ﹤0.01% 5982
2021
Q4 		$686K Buy
+22,100
New +$622K ﹤0.01% 6678
2015
Q3 		– Sell
-9,500
Closed -$315K – 4158
2015
Q2 		$315K Buy
+9,500
New +$260K ﹤0.01% 2769

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street's TVTX Position: Q1 2026 in Review

Jane Street reduced its Travere Therapeutics (TVTX) stake by 23% in Q1 2026, selling an estimated $2.69M and leaving 302,280 shares worth $8.98M. The position accounts for ﹤0.01% of the portfolio, ranked #2670.

Jane Street first reported a position in TVTX in Q1 2014 and has held it in 25 quarters since. The position peaked at $15M in Q4 2025. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

  • Jane Street held 302,280 shares of Travere Therapeutics worth $8.98M as of Q1 2026.
  • Jane Street sold 89,993 Travere Therapeutics shares in Q1 2026, an estimated $2.69M.
  • Travere Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #2670 holding.
  • Jane Street first reported a position in Travere Therapeutics in Q1 2014 and has held it in 25 quarters since.
  • Jane Street's Travere Therapeutics position peaked at $15M in Q4 2025.
  • 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.